These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11187883

  • 41. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F, Rotschild C, Beurrier P, Faradji A, Goudemand J, Polack B.
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [Abstract] [Full Text] [Related]

  • 42. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
    Delignat S, Dasgupta S, André S, Navarrete AM, Kaveri SV, Bayry J, André MH, Chtourou S, Tellier Z, Lacroix-Desmazes S.
    Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
    [Abstract] [Full Text] [Related]

  • 43. Characteristics of inhibitors in mild/moderate haemophilia A.
    Peerlinck K, Jacquemin M.
    Haemophilia; 2006 Dec; 12 Suppl 6():43-7. PubMed ID: 17123393
    [Abstract] [Full Text] [Related]

  • 44. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C, Schulz-Drost S, Khrenov AV, Saenko EL, Klinge J, Schneider H.
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [Abstract] [Full Text] [Related]

  • 45. Kinetic parameters of monoclonal antibodies ESH2, ESH4, ESH5, and ESH8 on coagulation factor VIII and their influence on factor VIII activity.
    Egler C, Albert T, Brokemper O, Zabe-Kühn M, Mayer G, Oldenburg J, Schwaab R.
    J Mol Recognit; 2009 Mar; 22(4):301-6. PubMed ID: 19266540
    [Abstract] [Full Text] [Related]

  • 46. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.
    Franchini M, Girelli D, Olivieri O, Bozzini C, Guiotto M, Zardini G, Lippi G, Manzato F, Gandin G.
    Haematologica; 2005 Mar; 90(3):ECR16. PubMed ID: 15753057
    [Abstract] [Full Text] [Related]

  • 47. The role of VWF in the immunogenicity of FVIII.
    Lacroix-Desmazes S, Repessé Y, Kaveri SV, Dasgupta S.
    Thromb Res; 2008 Mar; 122 Suppl 2():S3-6. PubMed ID: 18549909
    [Abstract] [Full Text] [Related]

  • 48. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM, Ahmad RU, Turecek PL, Schwarz HP.
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [Abstract] [Full Text] [Related]

  • 49. Influence of class I and II HLA alleles on inhibitor development in severe haemophilia A patients from the south of Brazil.
    De Barros MF, Herrero JC, Sell AM, De Melo FC, Braga MA, Pelissari CB, Machado J, De Souza Schiller S, De Souza Hirle L, Visentainer JE.
    Haemophilia; 2012 May; 18(3):e236-40. PubMed ID: 21726358
    [Abstract] [Full Text] [Related]

  • 50. Induction of immune tolerance, the future of the Registry.
    Ewing NP.
    Vox Sang; 1996 May; 70 Suppl 1():47-51. PubMed ID: 8869469
    [Abstract] [Full Text] [Related]

  • 51. Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor.
    Villard S, Lacroix-Desmazes S, Kieber-Emmons T, Piquer D, Grailly S, Benhida A, Kaveri SV, Saint-Remy JM, Granier C.
    Blood; 2003 Aug 01; 102(3):949-52. PubMed ID: 12676786
    [Abstract] [Full Text] [Related]

  • 52. [Characterization of factor VIII antibody epitopes from haemophilia A patients using cellulose bound FVIII peptide libraries].
    Albert T, Lange S, Oldenburg J, Graw J, Schramm W, Hanfland P, Brackmann HH, Schwaab R.
    Hamostaseologie; 2003 Feb 01; 23(1):13-7. PubMed ID: 12567194
    [Abstract] [Full Text] [Related]

  • 53. Current controversies in the formation and treatment of alloantibodies to factor VIII in congenital hemophilia A.
    Kruse-Jarres R.
    Hematology Am Soc Hematol Educ Program; 2011 Feb 01; 2011():407-12. PubMed ID: 22160066
    [Abstract] [Full Text] [Related]

  • 54. Immunochemical characterization of factor VIII inhibitors.
    Hoyer LW, Gawryl MS, de la Fuente B.
    Prog Clin Biol Res; 1984 Feb 01; 150():73-85. PubMed ID: 6431443
    [Abstract] [Full Text] [Related]

  • 55. Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.
    Fulcher CA, de Graaf Mahoney S, Roberts JR, Kasper CK, Zimmerman TS.
    Proc Natl Acad Sci U S A; 1985 Nov 01; 82(22):7728-32. PubMed ID: 2415970
    [Abstract] [Full Text] [Related]

  • 56. [Detection of alloantibodies against Factor VIII in plasma of patients with hemophilia A and its relationship with Factor VIIIC domain].
    Zhang LL, Yu ZQ, Wan CC, Zhang W, Zhang ZH, Ruan CG.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct 01; 21(5):1211-4. PubMed ID: 24156436
    [Abstract] [Full Text] [Related]

  • 57. [Immune mechanisms involved in the development and eradication of anti-factor VIII alloantibodies in hemophilia].
    Ishiguro A.
    Nihon Rinsho Meneki Gakkai Kaishi; 2011 Oct 01; 34(6):476-84. PubMed ID: 22214808
    [Abstract] [Full Text] [Related]

  • 58. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH, Marbet GA, Duckert F.
    Thromb Haemost; 1981 Dec 23; 46(4):699-705. PubMed ID: 6800051
    [Abstract] [Full Text] [Related]

  • 59. Endocytic receptor for pro-coagulant factor VIII: relevance to inhibitor formation.
    Navarrete AM, Dasgupta S, Teyssandier M, Repesse Y, Delignat S, André S, Bayry J, Kaveri SV, Lacroix-Desmazes S.
    Thromb Haemost; 2010 Dec 23; 104(6):1093-8. PubMed ID: 20886186
    [Abstract] [Full Text] [Related]

  • 60. Requirements for immune recognition and processing of factor VIII by antigen-presenting cells.
    van Haren SD, Wroblewska A, Fischer K, Voorberg J, Herczenik E.
    Blood Rev; 2012 Jan 23; 26(1):43-9. PubMed ID: 22036515
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.